Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
challenging, rewarding, exciting, collaborative, meaningful
Cosa ti piace di più del team di leadership?
Passion, Courage, Commitment, Intellect and Innovation
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
fast paced, constantly challenged, celebrate victories
Qual è la parte migliore del tuo compenso?
base, bonus and equity with monthly vesting after year 1
Che cosa ti rende più felice sul posto di lavoro?
Moving the company, the science and the function forward every day. Putting patients first
Quali sono alcune delle cose migliori della tuo team?
We have each others backs and we actually care about each other as people. We also have diverse and complimentary skills.
Other Employee Reviews for Karyopharm Therapeutics
×